Apotekamo
Pharmaceuticals manufacturing company.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
* | €2.5m Valuation: €14.6m 12.8x EV/Revenue | Seed | |
| Total Funding | 000k | ||
| SEK | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 383 % | 96 % | 66 % | (64 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (44 %) | (12 %) | (60 %) | (63 %) | (171 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Apotekamo operates as an online pharmacy platform targeting the Southeast European market. The company was initially established in Serbia and is a portfolio company of the Swedish venture builder EPTI. Apotekamo functions as a marketplace, connecting a large number of physical pharmacies into a single digital storefront. This model allows customers to purchase both over-the-counter and prescription medications online.
The company's business model includes providing digital services for third-party suppliers, such as order processing and payment solutions. Revenue is generated from the sale of pharmaceutical and cosmetic products through its online platform. Apotekamo aims to provide competitive pricing and a wide assortment of products, facilitated by its network of partner pharmacies. The platform offers home delivery services, ensuring discreet packaging for all orders.
Founded in 2018, Apotekamo has shown significant growth, highlighted by a 740% increase in order intake during the first half of 2022 compared to the same period in the previous year. The company has secured multiple funding rounds, including a €2.5 million investment in August 2022, which brought its pre-money valuation to €14.6 million. This funding is earmarked for further geographical expansion, marketing, and logistics development. A notable investor is former professional footballer Hasan Salihamidžić, who became the third-largest shareholder in 2022 and supports the company's marketing efforts.
The company's operational structure includes registered entities in Serbia and Bosnia and Herzegovina. The Serbian entity, APOTEKAMO DOO BEOGRAD-ZVEZDARA, focuses on computer programming, while APOTEKA "APOTEKAMO PHARM" handles the retail of pharmaceutical products. Srdjan Milic serves as the CEO of Apotekamo, with Dalila Kadić listed as a director for the local entities. The company expanded into Bosnia and Herzegovina in early 2022 after acquiring a local pharmacy.
Keywords: online pharmacy, Southeast Europe, e-commerce, pharmaceutical marketplace, prescription drugs, over-the-counter medicine, health products, digital pharmacy, venture-backed, EPTI, Serbian startup, marketplace, order processing, payment solutions, home delivery, health tech, pharmaceutical retail, cosmetics online, Angelgate AG, Hasan Salihamidžić